<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mohan Pammi, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph A Garcia-Prats, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 02, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H462631933">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal sepsis remains a major cause of neonatal mortality and morbidity in preterm and very low birth weight (VLBW) infants [
         <a href="#rid1">
          1-5
         </a>
         ].
        </p>
        <p>
         The clinical features and diagnosis of bacterial sepsis in the preterm infant will be reviewed here. The management and prevention of bacterial sepsis in the preterm infant are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">
          "Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation"
         </a>
         .)
        </p>
        <p>
         Sepsis in term and late preterm neonates is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">
          "Management and outcome of sepsis in term and late preterm neonates"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H462631940">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following terms will be used throughout this topic:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm infants
         </strong>
         are those born at &lt;34 weeks gestation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Late preterm infants
         </strong>
         (also called near-term infants) are those born between 34 and 36 completed weeks of gestation. Sepsis in late preterm infants is discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Very low birth weight (VLBW) infants
         </strong>
         are those with birth weights &lt;1500 g.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sepsis
         </strong>
         is defined as isolation of a pathogenic bacterium from a blood culture in a patient with signs or symptoms consistent with clinical sepsis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early-onset sepsis (EOS) is defined as sepsis that occurs within the first 72 hours after birth
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Late-onset sepsis (LOS) is defined as sepsis that occurs at &gt;72 hours of after birth
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Health care-associated infections
         </strong>
         are defined as infections (eg, sepsis) acquired in the hospital while receiving treatment for other conditions [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H176896156">
         <span class="h1">
          PATHOGENESIS
         </span>
        </p>
        <p class="headingAnchor" id="H176896163">
         <span class="h2">
          Early-onset sepsis (EOS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early-onset infection is usually due to vertical transmission by ascending contaminated amniotic fluid or during vaginal delivery from bacteria colonizing or infecting the mother's lower genital tract [
         <a href="#rid7">
          7
         </a>
         ]. The risk for sepsis increases from 1 to 4 percent in neonates born to mothers with chorioamnionitis.
        </p>
        <p>
         Maternal group B streptococcal (GBS) bacteriuria during the current pregnancy, prior delivery of an infant with GBS disease, and maternal colonization are some risk factors for early-onset GBS sepsis. (See
         <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">
          "Group B streptococcal infection in neonates and young infants", section on 'Risk factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H176896169">
         <span class="h2">
          Late-onset sepsis (LOS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Late-onset infections can be acquired by the two following mechanisms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal vertical transmission, resulting in initial neonatal colonization that evolves into later infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Horizontal transmission from direct contact with care providers or environmental sources (ie, health care-associated infections). Disruption of the intact skin or mucosa, which can be due to invasive procedures (eg, intravascular catheter), increases the risk of late-onset infection. (See
         <a class="local">
          'Risk factors'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H176897900">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of sepsis increases with decreasing gestational age and birth weight [
         <a href="#rid8">
          8-12
         </a>
         ]. In the United States, estimated rates of culture-proven sepsis among preterm very low birth weight (VLBW) infants are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early-onset sepsis (EOS)
         </strong>
         [
         <a href="#rid3">
          3,5,8,11
         </a>
         ]
         <strong>
          :
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         According to gestational age:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age &lt;25 weeks – 3.5 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age 25 to 28 weeks – 1.9 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age ≥29 weeks – 1 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         According to birth weight:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight &lt;400 to 500 g – 1.7 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 501 to 750 g – 2.2 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 751 to 1000 g – 1.9 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 1001 to 1250 g – 1.5 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 1251 to 1500 g – 0.8 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Late-onset sepsis (LOS)
         </strong>
         [
         <a href="#rid11">
          11,12
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         According to gestational age:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age ≤23 weeks – 32 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age 24 to 25 weeks – 22 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age 26 to 27 weeks – 11 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age 28 to 29 weeks – 5 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gestational age &gt;29 weeks – 2 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         According to birth weight:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight &lt;400 to 500 g – 43 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 501 to 750 g – 43 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 751 to 1000 g – 28 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 1001 to 1250 g – 15 percent
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Birth weight 1251 to 1500 g – 7 percent
        </p>
        <p>
        </p>
        <p>
         These incidence rates are based on data from two prospective registries in the United States (the National Institute of Child Health and Human Development Neonatal Research Network and the Vermont Oxford Network). Registries of preterm infants born in other developed countries (including Canada, England, Germany, Israel, Australia, and New Zealand) have yielded similar estimates [
         <a href="#rid9">
          9,10,13-15
         </a>
         ].
        </p>
        <p>
         The incidence of EOS in VLBW infants has remained stable since the 1990s; however, the incidence of LOS has decreased since the early 2000s among preterm infants in each gestational age category [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H462631954">
         <span class="h1">
          ETIOLOGIC AGENTS
         </span>
        </p>
        <p class="headingAnchor" id="H176897141">
         <span class="h2">
          Pathogens in EOS
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Escherichia coli
         </em>
         and group B
         <em>
          streptococcus
         </em>
         (GBS) are the most common causes of neonatal early-onset sepsis (EOS)  (
         <a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid8">
          8,10
         </a>
         ]. In very preterm infants,
         <em>
          E. coli
         </em>
         is more common as an EOS pathogen compared with GBS [
         <a href="#rid8">
          8-10,16
         </a>
         ]. This was illustrated in a study of the National Institute of Child Health and Human Development (NICHD) registry, in which the incidences of EOS due
         <em>
          t
         </em>
         o
         <em>
          E. coli
         </em>
         and GBS in very low birth weight (VLBW) infants were 5.1 and 2.1 per 1000 live births, respectively. For larger preterm infants with birth weights between 1500 and 2500 g, the incidences were 0.5 versus 0.4 per 1000 live births [
         <a href="#rid8">
          8
         </a>
         ]. In a study from the Canadian Neonatal Network (CNN), similar to studies from other countrie
         <em>
          s
         </em>
         ,
         <em>
          E. coli
         </em>
         and GBS were among the most common pathogens [
         <a href="#rid9">
          9
         </a>
         ]. In this study, coagulase-negative staphylococci (CoNS) were also commonly isolated. The relevance of CoNS as a pathogen in EOS is discussed below. (See
         <a class="local">
          'CoNS: Pathogen or contaminant?'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H176897798">
         <span class="h2">
          Pathogens in LOS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In preterm infants, the most common pathogens associated with late-onset sepsis (LOS) are CoNS,
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         , and gram-negative bacteria (
         <em>
          E
         </em>
         .
         <em>
          coli
         </em>
         ,
         <em>
          Klebsiella
         </em>
         ,
         <em>
          Enterobacter
         </em>
         )  (
         <a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">
          table 1
         </a>
         ). In a prospective observational study of very preterm infants born from 2018 through 2020, the relative frequencies of different pathogens among the 10,501 infants with LOS were as follows [
         <a href="#rid12">
          12
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CoNS (29 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          S.
         </em>
         <em>
          aureus
         </em>
         (23 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E
         </em>
         .
         <em>
          coli
         </em>
         (12 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Klebsiella
         </em>
         (8 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enterococcus (5 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         GBS (5 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Enterobacter
         </em>
         (4 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Pseudomonas
         </em>
         (3 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Serratia
         </em>
         (2 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fungi (5 percent)
        </p>
        <p>
        </p>
        <p>
         Similar findings were noted in a report based on data from the national neonatal infection surveillance system in Germany [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Candidal and viral infections are also important causes of late-onset infections in preterm neonates. These pathogens are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5028.html" rel="external">
          "Epidemiology and risk factors for Candida infection in neonates"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">
          "Clinical manifestations and diagnosis of Candida infection in neonates"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5029.html" rel="external">
          "Treatment of Candida infection in neonates"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3758071087">
         <span class="h2">
          CoNS: Pathogen or contaminant?
         </span>
         <span class="headingEndMark">
          —
         </span>
         While CoNS is commonly isolated in culture in preterm neonates, it may or may not reflect true infection. In some cases, the positive culture may be due to contamination or colonization of a catheter hub (eg, when blood cultures are drawn from indwelling catheters).
        </p>
        <p>
         The challenge of distinguishing true CoNS neonatal infection was illustrated in a retrospective study from a single tertiary center that identified 134 neonates with 149 episodes of positive CoNS culture from blood or a usual sterile site [
         <a href="#rid18">
          18
         </a>
         ]. Of these, 27 percent were considered proven infection (defined as two positive cultures and ≥2 clinical signs of sepsis [temperature instability, cardiorespiratory or gastrointestinal disturbances, lethargy or irritability]), 37 percent were considered probable infection (based upon blinded review of clinical nd laboratory data by two pediatric infectious disease specialists), and 36 percent were felt to reflect contamination. In this cohort, risk factors for proven and probable CoNS infection included birth weight &lt;2000 g, gestational age &lt;34 weeks, and presence of a central venous catheter.
        </p>
        <p>
         CoNS is most relevant as a pathogen in LOS; the importance of CoNS as a pathogen in EOS is unclear. The two studies described above (from the NICHD and CNN registries) reported markedly different rates of EOS due to CoNS. In the NICHD study, CoNS accounted for &lt;1 percent of EOS cases; whereas in the CNN study, CoNS accounted for 11 percent of cases of EOS in preterm neonates [
         <a href="#rid8">
          8,9
         </a>
         ]. These disparate findings are likely explained by differences in how EOS was defined in each study. The NICHD study required both a positive culture and ≥5 days of antibiotic therapy to define an episode of true EOS, whereas the CNN study required only a positive culture [
         <a href="#rid8">
          8,9
         </a>
         ]. Thus, while there were 149 positive blood cultures for CoNS in the NICHD study, only 3 were felt to represent true infection [
         <a href="#rid8">
          8
         </a>
         ]. By contrast, all cases of CoNS bacteremia in the CNN study were classified as EOS [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         Obtaining two blood cultures can help to distinguish between true CoNS infection versus contaminant, as discussed below. (See
         <a class="local">
          'Blood culture'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H462631968">
         <span class="h1">
          RISK FACTORS
         </span>
        </p>
        <p class="headingAnchor" id="H176900371">
         <span class="h2">
          Risk factors associated with prematurity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preterm infants are at increased risk for developing sepsis compared with term infants for the following reasons [
         <a href="#rid6">
          6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunocompromised host
         </strong>
         – Preterm infants have low levels of circulating maternal immunoglobulin G (IgG) because of the loss of transplacental transfer that occurs during the third trimester of pregnancy. Even in the presence of adequate IgG concentrations, opsonization and complement functions are reduced in preterm infants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epithelial mucosal barrier
         </strong>
         – The epithelial barriers in preterm infants are immature. In these infants, the skin and mucosal barriers are thin and delicate, readily break down, and provide minimal protection. Therapeutic interventions that increase the risk of health care-associated (ie, nosocomial) infection are more likely to be used in preterm infants [
         <a href="#rid6">
          6,19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Invasive devices
         </strong>
         – Invasive procedural devices, such as central venous and arterial catheterizations, urinary catheters, tracheal intubation, and feeding tubes, further compromise the epithelial barrier. In addition, total parenteral nutrition through central venous catheters (CVC) and administration of histamine blockers and proton pump inhibitors are associated with an increased risk of sepsis. The administration of lipids may also be an independent risk factor for bacterial and fungal sepsis. The use of invasive technology increases with decreasing gestational age, thereby increasing the risk of infection.
        </p>
        <p>
        </p>
        <p>
         These points were illustrated in a study from National Institute of Child Health and Human Development (NICHD) Neonatal Research Network that included 1313 very low birth weight (VLBW) infants with late-onset sepsis (LOS) [
         <a href="#rid4">
          4
         </a>
         ]. In this cohort, LOS was associated with the use of CVCs, parenteral nutrition, umbilical venous and arterial catheters (UVCs and UACs), and mechanical ventilation. The risk correlated with the duration of use of these interventions.
        </p>
        <p>
         A study conducted in 29 neonatal intensive care units in the United States identified the following risk factors in 94 patients with 116 health care-associated infections after adjusting for birth weight [
         <a href="#rid19">
          19
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total parenteral nutrition (relative risk [RR] 3.66, 95% CI 2.47-5.41)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mechanical ventilation (RR 3.2, 95% 2.12-4.82)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Arterial catheter (RR 2.43, 95% 1.50-3.95)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CVC (RR 2.37, 95% CI 1.61-3.50)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peripheral intravenous catheter (RR 2.02, 95% CI 1.38-2.95)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary catheter, chest tube, and tracheostomy were not independently associated with LOS in this cohort
        </p>
        <p>
        </p>
        <p>
         Type of central line (ie, peripherally inserted central catheter [PICC] versus UVC) does not appear to impact the risk of infection. In a retrospective matched cohort study of 540 preterm infants (&lt;30 weeks gestation), the rates of catheter-associated bloodstream infection were similar among infants who received a PICC on the first day after birth (day 1), those who received a UVC on day 1, and those who received a UVC on day 1 that was then changed for a PICC after four days or more (9.3, 7.8, and 8.2 per 1000 catheter days, respectively) [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         As discussed above, risk factors of coagulase-negative staphylococci (CoNS) neonatal infection included gestational age &lt;34 weeks, birth weight &lt;2000 g, and central venous line [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="local">
          'CoNS: Pathogen or contaminant?'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H176900018">
         <span class="h2">
          Maternal risk factors for EOS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maternal factors that are associated with an increased risk of EOS in the neonate, regardless of gestational age, include intra-amniotic infection (clinical chorioamnionitis), intrapartum maternal fever, maternal group B
         <em>
          streptococcus
         </em>
         (GBS) colonization, preterm birth, and prolonged rupture of the membranes (PROM). Though the duration of ruptured membranes is commonly considered when assessing the neonate's risk of infection, it is unclear whether PROM is an independent risk factor for sepsis in the absence of intra-amniotic infection [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         These factors are particularly pertinent to GBS infection. The approach to identifying pregnancies at risk for neonatal EOS and indications for maternal intrapartum antibiotic prophylaxis (IAP) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/438.html" rel="external">
          "Prevention of early-onset group B streptococcal disease in neonates", section on 'Identification of pregnancies at increased risk for early-onset neonatal GBS'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/438.html" rel="external">
          "Prevention of early-onset group B streptococcal disease in neonates", section on 'Intrapartum antibiotic prophylaxis'
         </a>
         .)
        </p>
        <p>
         Maternal GBS screening and IAP reduce but do not eliminate the risk of GBS infection in the neonate.
        </p>
        <p class="headingAnchor" id="H462631989">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H176899096">
         <span class="h2">
          Signs and symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         In preterm infants, the spectrum of symptoms of neonatal sepsis ranges from nonspecific subtle findings (eg, mild increase in apnea) to fulminant septic shock.
        </p>
        <p>
         Nonspecific signs observed in preterm infants with sepsis include [
         <a href="#rid22">
          22,23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory distress that ranges from mild tachypnea to respiratory failure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased respiratory support requirement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lethargy or hypotonia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increase in apnea
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Feeding intolerance
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Temperature instability
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypotension or evidence of poor perfusion
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increase in heart rate
        </p>
        <p>
        </p>
        <p>
         Because the signs and symptoms of sepsis can be subtle and nonspecific, any deviation from an infant's usual pattern of activity or feeding should be regarded as a possible indication of systemic bacterial infection. This was illustrated in a retrospective review of preterm infants with culture-proven coagulase-negative staphylococci (CoNS) bacteremia in which most infants on the first day of sepsis had new-onset apnea or bradycardia or new or increased respiratory support needs [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         The underlying etiologic agent may also influence the clinical presentation. For example, gram-negative sepsis is associated with a more fulminant course of severe sepsis and/or septic shock with a high risk of mortality [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Clinical signs associated with CoNS infection tend to be more subtle. In the previously mentioned study of neonatal CoNS infections, the most frequent presenting signs that prompted evaluation included hypoxia, apnea, bradycardia, lethargy, and increased gastric residuals [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Novel monitoring techniques using algorithms to detect pathologic heart rate variability, respiratory instability, and/or decrease spontaneous movement in the infant have shown promise in predicting onset of sepsis in preterm neonates [
         <a href="#rid26">
          26
         </a>
         ]. However, further study is needed before this strategy is routinely used in clinical practice.
        </p>
        <p class="headingAnchor" id="H176899819">
         <span class="h2">
          Severe sepsis and septic shock
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sepsis is considered severe when it is associated with cardiovascular or pulmonary compromise or multiorgan failure (ie, dysfunction in two or more organ systems).
        </p>
        <p>
         Clinical findings of neonatal shock include (see
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Distributive shock'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cool extremities, acrocyanosis, and pallor
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Changes in heart rate (initially tachycardia and, in the later stages, which may be terminal, bradycardia)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurologic changes such as lethargy, irritability, and nonresponsiveness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypotension
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oliguria
        </p>
        <p>
        </p>
        <p>
         In patients with severe sepsis, the host response is to produce systemic pro- and anti-inflammatory mediators, which contribute to multiorgan dysfunction. This is referred to as systemic inflammatory response syndrome (SIRS). (See
         <a class="medical medical_review" href="/z/d/html/6395.html" rel="external">
          "Sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         In the preterm infant, evidence suggests that systemic inflammation can contribute to the development of other neonatal morbidities such as necrotizing enterocolitis, lung disease, and intraventricular hemorrhage [
         <a href="#rid27">
          27-31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4991.html" rel="external">
          "Neonatal necrotizing enterocolitis: Pathology and pathogenesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">
          "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Septic shock results in inadequate tissue perfusion and lactic acidosis. Shock in this setting is likely multifactorial, resulting from reduced systemic vascular resistance, reduced circulating intravascular volume due to capillary leak and third spacing, and, potentially, myocardial dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Distributive shock'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H462631996">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H1198967891">
         <span class="h2">
          Asymptomatic neonates at risk for EOS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach to evaluating preterm neonates who have risk factors for early-onset group B streptococcus infection is summarized in the figure  (
         <a class="graphic graphic_algorithm graphicRef131141" href="/z/d/graphic/131141.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5981.html" rel="external">
          "Management of neonates at risk for early-onset group B streptococcal infection", section on 'Neonates &lt;35 weeks gestation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1166907519">
         <span class="h2">
          Symptomatic neonates
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because the signs and symptoms of sepsis are subtle and nonspecific, laboratory evaluation is performed in any infant with physical findings consistent with sepsis or who deviates significantly from the usual pattern of activity or feeding.
        </p>
        <p class="headingAnchor" id="H462632003">
         <span class="h3">
          Blood culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         The blood culture makes the definitive diagnosis of sepsis and can be obtained by venous or arterial puncture or by sampling from a newly inserted arterial or venous catheter. The sensitivity of blood culture to detect neonatal bacteremia depends on the number of cultures obtained and volume of blood used to inoculate each culture bottle. However, sensitivity may be impaired because of inability to obtain adequate volume of blood, especially from sick very low birth weight (VLBW) infants. In addition, the use of antepartum antibiotics may negatively impact blood culture sensitivity.
        </p>
        <p>
         A minimum volume of 0.5 mL of blood is required for blood cultures, but a higher volume may be required to detect low colony-count sepsis (&lt;4 colony-forming units/mL) [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
         Obtaining more than one blood culture is helpful in the interpretation of blood culture results. If coagulase-negative staphylococci (CoNS) are isolated from two or more blood cultures, true bacteremia is more likely than contamination of the specimen, which may be reflected by a single positive blood culture [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         However, in preterm infants, because of the difficulty in obtaining an adequate blood volume for culture, the result from only a single positive blood culture may be available. In this setting, it is challenging to decide whether or not there is true infection from CoNS [
         <a href="#rid6">
          6
         </a>
         ]. The clinician must decide on further management based on the clinical setting (eg, response to empiric therapy and clinical suspicion for infection based on gestational age and other risk factors [
         <a href="#rid18">
          18
         </a>
         ]). (See
         <a class="local">
          'CoNS: Pathogen or contaminant?'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H176901095">
         <span class="h3">
          Other cultures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cultures of other sites may be indicated in the preterm infant who is suspected of having sepsis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebrospinal fluid (CSF) culture
         </strong>
         – Lumbar puncture (LP) is not necessary for every preterm neonate undergoing sepsis evaluation if the index of suspicion for infection is low (eg, a neonate undergoing evaluation due to increased episodes of apnea who otherwise appears clinically well). However, LP should be performed if the neonate is ill appearing or has other concerning findings (irritability, bulging fontanelle, seizures). In addition, LP should be performed if the blood culture is positive. In some cases, it may not be feasible to perform LP because the neonate is too unstable to tolerate the procedure. In these cases, the LP should be deferred until the neonate is stable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If LP is performed, CSF should be sent for Gram stain, routine culture, cell count with differential, and protein and glucose concentrations. The interpretation of CSF needs to account for variations due to gestational age, chronologic age, and birth weight  (
         <a class="graphic graphic_table graphicRef54464" href="/z/d/graphic/54464.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">
          "Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Urine culture
         </strong>
         – Urine culture obtained by catheter or bladder tap should be included in the sepsis evaluation for infants &gt;6 days of age. A urine culture need not be routinely performed in the evaluation of an infant ≤6 days of age, because a positive urine culture in this setting is a reflection of high-grade bacteremia rather than an isolated urinary tract infection. (See
         <a class="medical medical_review" href="/z/d/html/4959.html" rel="external">
          "Urinary tract infections in neonates", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4959.html" rel="external">
          "Urinary tract infections in neonates", section on 'Preterm infants'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Urine culture'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other sites
         </strong>
         – In patients with late-onset infection, cultures should be obtained from any other potential foci of infection (eg, purulent eye drainage; pustules; skin lesions; bone, joint, or peritoneal fluid; or tracheal aspirates in mechanically ventilated infants).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H462632010">
         <span class="h3">
          Inflammatory markers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Efforts have not been successful in identifying tests that can accurately and rapidly predict neonatal sepsis while awaiting blood culture results. The most widely studied tests are neutrophil counts, C-reactive protein (CRP), and procalcitonin. Other tests that have been evaluated include interleukin-6, interleukin-8, and tumor necrosis factor-alpha levels; however, these studies are primarily used in the research setting and are not routinely available in hospital laboratories [
         <a href="#rid34">
          34,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Laboratory tests'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H176900390">
         <span class="h4">
          Neutrophil counts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both the absolute neutrophil and the ratio of immature to total neutrophil counts (I/T ratio) have been used as markers for neonatal sepsis. However, as is true for term and late preterm infants, these tests are not useful to accurately predict neonatal sepsis. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Complete blood count'
         </a>
         .)
        </p>
        <p>
         This was illustrated in a multicenter study of 166,092 infants that included both term and preterm infants with a mean gestational age of 34.6 weeks who were suspected to have early-onset sepsis (EOS) [
         <a href="#rid36">
          36
         </a>
         ]. Although the probability of a positive blood culture within the first three days of age increased with a low white blood cell count (&lt;5000/microL), absolute neutropenia (&lt;1000 neutrophils/microL), and an elevated I/T ratio, sensitivities of all indices were poor and insufficient to accurately diagnose neonatal sepsis.
        </p>
        <p>
         In another analysis of the same cohort of patients, late-onset sepsis (LOS; defined as a positive culture between day of age 4 and 120) was associated with both low and high white blood cell counts (&lt;1000 and &gt;50,000/microL), high absolute neutrophil count (&gt;17,670/microL), elevated I/T ratio of 0.2 or higher, and low platelet count (&lt;50,000/microL) [
         <a href="#rid36">
          36
         </a>
         ]. However, the sensitivity of these indices was inadequate to reliably make the diagnosis of LOS.
        </p>
        <p class="headingAnchor" id="H176900446">
         <span class="h4">
          C-reactive protein
         </span>
         <span class="headingEndMark">
          —
         </span>
         CRP is an acute phase reactant synthesized in the liver that increases in inflammatory conditions, including sepsis. Although an elevated CRP (&gt;1 mg/dL) is 90 percent sensitive in detecting neonatal sepsis, its poor specificity makes it a poor predictor for neonatal sepsis as it is elevated in other noninfectious inflammatory conditions (eg, maternal fever, fetal distress) [
         <a href="#rid37">
          37
         </a>
         ]. CRP levels do not seem to be affected by gestational age [
         <a href="#rid38">
          38
         </a>
         ], and serial CRPs have been found to be useful to follow resolution of infection and guide antibiotic therapy [
         <a href="#rid35">
          35,39-42
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Other inflammatory markers'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H462632017">
         <span class="h3">
          Molecular diagnostic methods
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular techniques (eg, polymerase chain reaction [PCR]) may offer a reliable and more timely method for diagnosis than bacterial cultures as they have a more rapid turnaround time, require smaller sample volumes, and are not affected by the administration of antepartum antibiotics [
         <a href="#rid43">
          43,44
         </a>
         ]. While molecular methods are increasingly used to assist in the diagnosis of central nervous system (CNS) infections in infants and children, there role in the routine evaluation of suspected neonatal sepsis (ie, to detect bacteremia) is limited.
        </p>
        <p>
         The role of PCR testing in neonatal meningitis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">
          "Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Polymerase chain reaction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H176901443">
         <span class="h3">
          Other studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other studies are often obtained to differentiate sepsis from conditions with similar presentations. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest radiography in patients with respiratory distress to differentiate from pneumonia and respiratory distress syndrome (see
         <a class="medical medical_review" href="/z/d/html/5004.html" rel="external">
          "Neonatal pneumonia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5055.html" rel="external">
          "Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum glucose to differentiate from hypoglycemia (see
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Clinical presentation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic screening to differentiate from inborn errors of metabolism (see
         <a class="medical medical_review" href="/z/d/html/2936.html" rel="external">
          "Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2912.html" rel="external">
          "Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulse oximetry screening and echocardiography to differentiate from critical congenital heart disease (see
         <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">
          "Identifying newborns with critical congenital heart disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3751213380">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Proven sepsis
         </strong>
         – The diagnosis of sepsis is based upon isolating a pathogenic organism in culture. Only a small fraction of neonates who undergo sepsis evaluation are ultimately diagnosed with proven sepsis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Probable sepsis
         </strong>
         – A subset of neonates have sterile blood cultures yet have a clinical course consistent with sepsis. In these infants, a clinical diagnosis of "probable sepsis" can be made based upon clinical assessment, subsequent laboratory tests, and the clinical course. These infants should also be evaluated for other causes of their clinical findings  (
         <a class="graphic graphic_table graphicRef100409" href="/z/d/graphic/100409.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If no alternative diagnosis is established to explain the findings, a complete course of antibiotic therapy is generally warranted in neonates with a clinical diagnosis of "probable sepsis". (See
         <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">
          "Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Antibiotic therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Unlikely infection
         </strong>
         – Neonates with mild and/or transient symptoms who remain clinically well with negative cultures at 36 to 48 hours are unlikely to have sepsis. Empiric antibiotic therapy should be discontinued after 36 to 48 hours in these neonates.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H462632031">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because the findings are nonspecific, it is often difficult to differentiate neonatal sepsis from other diseases. As a result, empiric antibiotic therapy is started until blood culture results are available. (See
         <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">
          "Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Empiric antibiotic therapy'
         </a>
         .)
        </p>
        <p>
         The differential diagnosis for neonatal sepsis in the preterm infant is similar to that seen in the term or near-term infant  (
         <a class="graphic graphic_table graphicRef100409" href="/z/d/graphic/100409.html" rel="external">
          table 3
         </a>
         ). Clinical history, appropriate culture(s), molecular diagnostic assays, serology, imaging, and screening studies usually distinguish neonatal sepsis from other systemic infections as well as metabolic and other conditions, which may present with similar findings. (See
         <a class="local">
          'Evaluation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fungal infection – Candidiasis (see
         <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">
          "Clinical manifestations and diagnosis of Candida infection in neonates"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral infections – Enteroviruses, herpes simplex virus, cytomegalovirus, influenza viruses, and respiratory syncytial virus (see
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spirochetal infections – Syphilis (see
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parasitic infections – Congenital malaria and toxoplasmosis (see
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4795.html" rel="external">
          "Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome", section on 'Vertical transmission'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other bacterial infections include urinary tract infection (particularly in the setting of a congenital genitourinary tract malformation), osteomyelitis or septic arthritis, pneumonia, and tuberculosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Noninfectious conditions include neonatal respiratory distress, inborn errors of metabolism, critical congenital heart disease, and hypoglycemia (see
         <a class="local">
          'Other studies'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3486183666">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110817.html" rel="external">
          "Society guideline links: Sepsis in neonates"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/112235.html" rel="external">
          "Society guideline links: Group B streptococcal infection in pregnant women and neonates"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2743592228">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17189.html" rel="external">
          "Patient education: Sepsis in newborn babies (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H462632046">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Importance
         </strong>
         – Neonatal sepsis is a major cause of neonatal mortality and morbidity in preterm and very low birth weight (VLBW; &lt;1500 g) infants. The risk of neonatal sepsis increases with decreasing gestational age (GA) and birth weight (BW). (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Incidence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early- versus late-onset infection
         </strong>
         – Neonatal sepsis is classified by the infant's age at the time of onset of symptoms:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Early-onset sepsis (EOS; onset within 72 hours after birth)
         </strong>
         – EOS occurs in approximately 2 percent of VLBW infants. It is due to maternal vertical transmitted bacteria. Group B
         <em>
          Streptococcus
         </em>
         (GBS) and
         <em>
          Escherichia
         </em>
         <em>
          coli
         </em>
         are the most commonly isolated pathogens  (
         <a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Early-onset sepsis (EOS)'
         </a>
         above and
         <a class="local">
          'Incidence'
         </a>
         above and
         <a class="local">
          'Pathogens in EOS'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Late-onset sepsis (LOS; onset at &gt;72 hours after birth)
         </strong>
         – LOS occurs in approximately 10 to 40 percent of VLBW infants, depending upon GA and BW. LOS is due to bacteria acquired at birth or from environmental horizontal transmission. Coagulase-negative staphylococci (CoNS),
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         , and gram-negative bacteria (
         <em>
          E
         </em>
         .
         <em>
          coli
         </em>
         ,
         <em>
          Klebsiella
         </em>
         ,) are the most commonly isolated pathogens  (
         <a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Late-onset sepsis (LOS)'
         </a>
         above and
         <a class="local">
          'Incidence'
         </a>
         above and
         <a class="local">
          'Pathogens in LOS'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – Risk factors that increase the likelihood of sepsis in preterm infants compared with term infants include their decreased immunocompetence, poorer epithelial mucosal barrier, and increased prevalence of invasive procedures and interventions associated with infection (eg, central venous catheters, mechanical ventilation). (See
         <a class="local">
          'Risk factors associated with prematurity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – In preterm infants, the spectrum of symptoms of neonatal sepsis ranges from nonspecific subtle findings (eg, mild increase in apnea) to fulminant septic shock. The most frequent signs observed in preterm infants with sepsis include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Respiratory distress that ranges from mild tachypnea to respiratory failure
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased respiratory support requirement
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lethargy or hypotonia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increase in apnea
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Feeding intolerance
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Temperature instability
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypotension or evidence of poor perfusion
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increase in heart rate
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Because the signs and symptoms of sepsis can be subtle and nonspecific, systemic bacterial infection should be suspected if the neonate deviates significantly from the usual pattern of activity or feeding. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Asymptomatic neonates at risk for EOS
         </strong>
         – The approach to evaluating preterm neonates who have risk factors for early-onset GBS infection is summarized in the figure  (
         <a class="graphic graphic_algorithm graphicRef131141" href="/z/d/graphic/131141.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5981.html" rel="external">
          "Management of neonates at risk for early-onset group B streptococcal infection", section on 'Neonates &lt;35 weeks gestation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Symptomatic neonates
         </strong>
         – The laboratory evaluation of neonates with clinically suspected sepsis minimally includes a blood culture. Other tests may include lumbar puncture, inflammatory markers (eg, C-reactive protein, white blood cell count with differential), urine culture (for infants &gt;6 days of age), chest radiograph (if there are respiratory symptoms), and cultures of any other potential foci of infection (eg, skin pustule, tracheal aspirates in mechanically ventilated infants). Empiric antibiotic therapy is generally initiated while awaiting culture results. (See
         <a class="local">
          'Evaluation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">
          "Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Empiric antibiotic therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of sepsis is based upon isolating a pathogenic organism in culture. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of neonatal sepsis includes other systemic infections, inborn errors of metabolism, critical congenital heart disease, and neonatal respiratory distress. These conditions are differentiated from sepsis by the clinical history and laboratory evaluation, including culture. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 2006; 35:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 2003; 27:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005; 24:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polin RA, Denson S, Brady MT, et al. Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics 2012; 129:e1104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018; 142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sgro M, Shah PS, Campbell D, et al. Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008. J Perinatol 2011; 31:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96:F9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Hansen NI, Bell EF, et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA 2015; 314:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flannery DD, Edwards EM, Coggins SA, et al. Late-Onset Sepsis Among Very Preterm Infants. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makhoul IR, Sujov P, Smolkin T, et al. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis 2005; 40:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daley AJ, Isaacs D, Australasian Study Group for Neonatal Infections. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 2004; 23:630.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tröger B, Göpel W, Faust K, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J 2014; 33:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rønnestad A, Abrahamsen TG, Medbø S, et al. Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics 2005; 115:e262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piening BC, Geffers C, Gastmeier P, Schwab F. Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection. PLoS One 2017; 12:e0180134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Healy CM, Baker CJ, Palazzi DL, et al. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol 2013; 33:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001; 139:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shalabi M, Adel M, Yoon E, et al. Risk of Infection Using Peripherally Inserted Central and Umbilical Catheters in Preterm Neonates. Pediatrics 2015; 136:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ofman G, Vasco N, Cantey JB. Risk of Early-Onset Sepsis following Preterm, Prolonged Rupture of Membranes with or without Chorioamnionitis. Am J Perinatol 2016; 33:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffin MP, Lake DE, O'Shea TM, Moorman JR. Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res 2007; 61:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bekhof J, Reitsma JB, Kok JH, Van Straaten IH. Clinical signs to identify late-onset sepsis in preterm infants. Eur J Pediatr 2013; 172:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maayan-Metzger A, Linder N, Marom D, et al. Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants. Acta Paediatr 2000; 89:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi R, Kommers D, Oosterwijk L, et al. Predicting Neonatal Sepsis Using Features of Heart Rate Variability, Respiratory Characteristics, and ECG-Derived Estimates of Infant Motion. IEEE J Biomed Health Inform 2020; 24:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006; 19:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103:766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris MC, D'Angio CT, Gallagher PR, et al. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 2005; 147:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88:F209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999; 158 Suppl 1:S18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kellogg JA, Ferrentino FL, Goodstein MH, et al. Frequency of low level bacteremia in infants from birth to two months of age. Pediatr Infect Dis J 1997; 16:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996; 129:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med 2018; 31:1646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lacaze-Masmonteil T, Rosychuk RJ, Robinson JL. Value of a single C-reactive protein measurement at 18 h of age. Arch Dis Child Fetal Neonatal Ed 2014; 99:F76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995; 14:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawamura M, Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr 1995; 84:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wasunna A, Whitelaw A, Gallimore R, et al. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr 1990; 149:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Venkatesh M, Flores A, Luna RA, Versalovic J. Molecular microbiological methods in the diagnosis of neonatal sepsis. Expert Rev Anti Infect Ther 2010; 8:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oeser C, Pond M, Butcher P, et al. PCR for the detection of pathogens in neonatal early onset sepsis. PLoS One 2020; 15:e0226817.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 88740 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16556647" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Estimating the causes of 4 million neonatal deaths in the year 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14510320" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Infections in VLBW infants: studies from the NICHD Neonatal Research Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12140299" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12165580" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15999007" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22451708" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology and diagnosis of health care-associated infections in the NICU.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30455344" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Management of Neonates Born at≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21518717" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21527901" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20876594" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Neonatal infections in England: the NeonIN surveillance network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26348753" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36366916" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Late-Onset Sepsis Among Very Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15655738" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15247601" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24030351" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15687417" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28640920" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22499081" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11743507" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26574592" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Risk of Infection Using Peripherally Inserted Central and Umbilical Catheters in Preterm Neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26469992" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Risk of Early-Onset Sepsis following Preterm, Prolonged Rupture of Membranes with or without Chorioamnionitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17237726" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Heart rate characteristics and clinical signs in neonatal sepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23271492" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Clinical signs to identify late-onset sepsis in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10914964" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11099593" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31295130" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Predicting Neonatal Sepsis Using Features of Heart Rate Variability, Respiratory Characteristics, and ECG-Derived Estimates of Infant Motion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16645492" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Neonatal infection and long-term neurodevelopmental outcome in the preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10103300" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16227031" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12719394" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10592094" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Inflammatory mechanisms in neonatal chronic lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109140" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Frequency of low level bacteremia in infants from birth to two months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8765627" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Volume of blood required to detect common neonatal pathogens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15102726" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Diagnostic markers of infection in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28427289" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Biomarkers for diagnosis of neonatal sepsis: a literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22531232" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Use of the complete blood cell count in late-onset neonatal sepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24008814" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Value of a single C-reactive protein measurement at 18 h of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7638010" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11750194" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10469768" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7734887" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The usefulness of serial C-reactive protein measurement in managing neonatal infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2332012" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : C-reactive protein and bacterial infection in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20818947" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Molecular microbiological methods in the diagnosis of neonatal sepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31978082" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : PCR for the detection of pathogens in neonatal early onset sepsis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
